Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

Completed · Phase 2/Phase 3

Conditions studied: Schizophrenia

In brief

Study to learn if the alternate formulation is effective in agitated schizophrenic patients

Key facts

Study ID

NCT00036127

Run by

Otsuka Pharmaceutical Development & Commercialization, Inc.

Starts

2002-04-01

Expected to finish

2003-01-01

Last updated by the study team

2013-11-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Agitated schizophrenic patients

Where it is running

• Local Institution — Anaheim, California, United States
• Local Institution — Cerritos, California, United States
• Local Institution — Chula Vista, California, United States
• Local Institution — Rosemead, California, United States
• Local Institution — San Diego, California, United States
• Local Institution — Atlanta, Georgia, United States
• Local Institution — Macon, Georgia, United States
• Local Instituton — Hoffman Estates, Illinois, United States
• Local Institution — Las Vegas, Nevada, United States
• Local Institution — Nashua, New Hampshire, United States
• Local Institution — New York, New York, United States
• Local Institution — Beachwood, Ohio, United States
• Local Institution — Philadelphia, Pennsylvania, United States
• Local Institution — Charleston, South Carolina, United States
• Local Institution — Houston, Texas, United States
• Local Institution — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.